This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine. ’
What could the implications be for patients on their medical cannabis journey? Rescheduling would ease those research barriers, improving access to data and education around the plant and opening the door to fully explore the medical benefits cannabis could provide. What does rescheduling cannabis mean for medical cannabis patients?
The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.
Patients authorized to legally use medical cannabis frequently substitute it in place of benzodiazepines, according to a pair of new studies published this week. According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”
Some four in ten adults who reported using both marijuana and opioids within the past year acknowledge either decreasing or ceasing their consumption of opioids as a result of substituting cannabis, according to an analysis of survey data published in the journal PLOS One. ” authors concluded.
A team of researchers affiliated with the University of Miami School of Nursing are collecting epidemiological data to better evaluate how cannabis consumers, and patients in particular, are responding to the COVID-19 pandemic. So, we are combining our skills to do our part to provide that data. Vidot, who is leading the study.
The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”
While the UK-based team found promising data, it comes with a fair share of caveats. The post Study: ADHD patients benefited from medical cannabis appeared first on Leafly.
Medical Marijuana Leads To Less Hospitalizations For IBS Patients. New data shows IBS patients who used marijuana experienced less hospitalizations and shorter visits compared to non-users. The post Medical Marijuana Leads To Less Hospitalizations For IBS Patients appeared first on The Fresh Toast.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. In addition, IDPH worked toward the establishment of a new patient tracking system and staff were trained on its functions and capabilities. Refresh QA plans with a focus on staffing assignments.
Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.
Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. The new data shows 19,990 adults arrested for the same offense in 2019. cannabis arrest data since 2008. cannabis arrest data since 2008.
With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.
New Data About Cancer And Cannabis New data bout cancer and cannabis give physicians and researchers information about how to talk with patients. The post New Data About Cancer And Cannabis appeared first on The Fresh Toast.
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.
MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Back to our study.
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. IDFPR FY2025 goals include: Continue working with CROO and the legislature to pass legislation to expand access to cannabis for medical patients. Find detailed information about this topic here.)
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
In nursing school, I wrote my dissertation on the role of the nurse when caring for patients using cannabis therapeutically, knowing that nurses are often the first healthcare professional to whom patients disclose their cannabis use. I remain in awe of these patients to this day.
Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. million) came from sales by caregivers to patients. Only the state’s lobster industry and potato industry bring in more annual revenue.
Pistil Data recently releases its market reports on the covering the top cannabis brands, products, and trends in every major cannabis category including vape, flower, edibles, and more. Pistil Data released market reports for 12 states, including Illinois. To qualify and receive a medical patient card at a discounted rate, visit here.
Starting this week, the Cannabis Control Commission (Commission)’s Open Data Platform composed of application and license, agent registration and ownership, and sales and product distribution information is now available on their main website at. MassCannabisControl.com/open- data. View the Open Data Platform.
The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”
Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. Anonymized data also helps scientists better understand the cannabis plant and what products and chemical profiles are most effective for treating different conditions and symptoms.
People with AD are roughly around the age of 65 and according to recent data, increase every five to six years. The post Could CBD Help Patients With Alzheimer’s? It’s the most common cause of dementia, a term for memory loss. Although there isn’t a cure for Alzheimer’s, medical experts are continuing to […].
Releaf is a free mobile app to help patients track, learn from, and improve their use of medical cannabis. The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective. Patients can learn more by visiting ReleafApp.com.
million patients in 2022, a sharp increase from the 3.1 This data aligns with Americans’ rising acceptance of cannabis. While there have been some drops in medical patient registration in states with adult-use (recreational) programs, pandemic-era programs also directly attributed to part of the increase in patient registration.
Follow strict patient verification and dispensing rules. Under the Therapeutic Goods Act and respective State/Territory guidelines, advertising medicinal cannabis directly to patients can violate advertising laws. Data Privacy 29. What data privacy obligations do cannabis businesses have? Competition Law 30.
The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine. Subjects receiving treatment reported no adverse effects.
The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.
The objective of this study was to determine how the use of medical cannabis affects prescribed opioid usage in chronic pain patients. Healer conducted an online convenience sample survey of patients from three medical cannabis practice sites who had reported using opioids. Read full published study.
Data published today in the weekly publication of the US Centers for Disease Control and Prevention provides further evidence that the presence of vitamin E acetate (oil) in illicit market, e-liquid vape products is likely associated with EVALI (e-cigarette or vaping product use-associated lung injury).
1 When we invited Cannigma readers to try Slumber’s Deep Zzzs gummies for sleep, we were particularly interested in digging into the data on sleep quality – not just total sleep time. 2 While the data collection effort did not include a control group, the prime findings were found to be statistically significant.
– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Declining circulating tumor cell (CTC) count in treated patients.
Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Even still, the “odds of a cancer patient using marijuana in the past year were essentially flat between 2013 and 2018.”
Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?
A study published earlier this year reveals a simple but interesting pattern: When patients with ADHD consume more cannabis, they require fewer prescription drugs. According to the study’s research team , patients who consume medical marijuana report a “higher occurrence of stopping all ADHD medications.”
Separate data from Minnesota similarly reports that many patients enrolled in the state’s medical cannabis registry show a “clinically meaningful” reduction in post-traumatic stress symptoms.
An Analysis of Nationwide EVALI Data. Additionally, this one policy change made the odds of vaping as the primary form of consumption 40% lower, demonstrating that patients were ready and willing to switch from vaping to smoking home-grown cannabis once they were able.
Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.
Instead of directly surveying the young patients, they reached out to their caregivers – the individuals who deeply understand the daily routines, challenges, and treatments of these children. This paves the way for a more integrated approach to care where CBD can be used alongside traditional treatments to optimize patient outcomes.
Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. RoC also works to increase patients’ access to medical cannabis by helping U.S. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content